AzTrials
AzTrials

AnxietyNCT07256093

The Effectiveness of Acceptance and Commitment Therapy (ACT) on Dysfunctional Attitudes and Difficulties in Emotion Regulation Among University Students in Malaysia

A study testing Acceptance and Commitment Therapy (ACT) in people with Anxiety and Depression, run by Universiti Sains Malaysia at 1 site in Malaysia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if Acceptance and Commitment Therapy (ACT) can reduce dysfunctional attitudes and difficulties in emotion regulation among university students in Malaysia.The main questions it aims to answer are: Will participants who receive ACT show statistically significant reduction in… Read more about this study

Who is it for?
Ages 18 to 32 years
Conditions the study is for
Anxiety, Depression, Stress
What is being tested?
Acceptance and Commitment Therapy (ACT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteMalaysia
Study dates
10 Feb 2025to 25 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 32 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Malaysian citizens
  • currently enrolled as a university student
  • be proficient in both Malay and English languages
  • aged between 18 and 32 years old
  • reported mild to moderate depression, anxiety, and/or stress levels according to the DASS-21

Who cannot join

  • reported severe depression, anxiety, and/or stress on the DASS-21
  • expected to graduate before study ends
  • had been diagnosed with any psychological disorder prior to the study
  • were currently receiving psychotherapeutic medication and/or psychological interventions.

Trial locations and contacts

1 site in 1 country.

Malaysia1 site
  • Universiti Sains Malaysia

    Kuala Lumpur

Other trials in Malaysia

About this study

Official title: The Effectiveness of Acceptance and Commitment Therapy (ACT) on Dysfunctional Attitudes and Difficulties in Emotion Regulation Among University Students in Malaysia.

The goal of this clinical trial is to learn if Acceptance and Commitment Therapy (ACT) can reduce dysfunctional attitudes and difficulties in emotion regulation among university students in Malaysia.The main questions it aims to answer are:

  • Will participants who receive ACT show statistically significant reduction in dysfunctional attitudes scores compared to those in the control group?
  • Will participants who receive ACT show statistically significant reduction in difficulties in emotion regulation scores compared to those in the control group?
  • Will participants who receive ACT show statistically significant reduction in dysfunctional attitudes scores from pre-test to intermediate-test and from pre-test to post-test?
  • Will participants who receive ACT show statistically significant reduction in difficulties in emotion regulation scores from pre-test to intermediate test and from pre-test to post-test?
Read more

Researchers will compare ACT group to a waitlist control group to see if ACT work to reduce dysfunctional attitudes and difficulties in emotion regulation.

Participants in the ACT group will

  • attend six weekly individual sessions of ACT intervention (1 hour per session) conducted online
  • complete the outcome measures at three different time points (week 1, week 3, and week 6)

Meanwhile, participants in the waitlist control group

  • will not receive any intervention during the data collection period
  • will be asked to complete same outcome measures at three different time points (week 1, week 3, and week 6)
Being tested
Acceptance and Commitment Therapy (ACT)
Medical subject headings
Anxiety Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Acceptance and Commitment Therapy (ACT)Other

    Six sessions of ACT were conducted

    Session 1:

    Introduction. Theme: Broaden your horizon. Values and value-based actions. Identifying what matters the most in your life and acting accordingly.

    Session 2: Theme: Present moment. Mindfully notice your internal and external experiences, notice the movement of your breath. Live in the present moment. To address difficulties in emotion regulation.

    Session 3: Theme: Cognitive defusion. The power of thoughts. Identify your unwanted thoughts and emotions and learn to describe, name, and welcome them. To address dysfunctional attitudes.

    Session 4: Theme: The observer's stance. Learn to view your thoughts and emotions from an observer's stance. To address difficulties in emotion regulation.

    Session 5: Theme: Toward an attitude of acceptance. Let go of your struggle and learn acceptance towards your wakefulness and unwanted thoughts. To address dysfunctional attitudes.

    Session 6: Theme: Summary of the programme. Plans committed action.

Study groups in NCT07256093
Study groupRoleWhat they receive
ACT Intervention GroupExperimentalParticipants in the intervention group attended six weekly individual sessions of ACT intervention (1 hour per session) conducted online via the Webex platform.
Receives: Other: Acceptance and Commitment Therapy (ACT)
Waitlist Control GroupNo interventionParticipants in the control group were placed on a waitlist and completed the same outcome measures at three different time points (week 1, week 3, and week 6). After the completion of data collection, they were then divided into two groups and attended two group sessions of ACT (1.5 hours per session), each covering three of the six ACT main components.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difficulties in Emotion Regulation

    It is measured as the total score on the Difficulties in Emotion Regulation Scale-18 Malay, where a higher score indicates a greater degree of difficulties in emotion regulation.

    Measured: Baseline, Week 3, and Week 6

  2. Dysfunctional Attitudes

    It is measured as the total score on the Dysfunctional Attitude Scale-Malay, where a higher score indicates a greater degree of dysfunctional attitude.

    Measured: Baseline, Week 3, and Week 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Dec 2025
  2. Study start10 Feb 2025
  3. Primary completion20 Mar 2025
  4. Study completion25 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07256093
Sponsor's protocol ID
USM/JEPeM/KK/24080672
Status last verified
Oct 2025
First submitted
19 Nov 2025
Last updated
30 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Acceptance and Commitment Therapy (ACT) in people with Anxiety and Depression, run by Universiti Sains Malaysia at 1 site in Malaysia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Malaysia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difficulties in Emotion Regulation (time frame: Baseline, Week 3, and Week 6). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT07256093 | AzTrials